China proposes pharmaceutical patent linkage scheme

The China Food and Drug Administration (CFDA) is planning to introduce a patent linkage scheme that will require a generic applicant to make a non-infringement declaration against an innovator’s patent portfolio
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: